NOVEL is an Award Winning Team of Experienced Professionals with Expertise in Health Economics and Outcomes Research, Market Access, Pricing, Payer Strategy, Publications, GVD and Reimbursement.
Our Team is Comprised of Strategists, ex-Payers, HEOR Experts and Market Access Professionals.
NOVEL's Team has Published More than 160+ Peer-Reviewed Publications in Top Journals and Conferences.
Our Team has Experience Leading Projects for Majority of Top 50 Pharmaceutical and Medical Device Companies. Novel Health has led US & Global Projects on Blockbuster and Niche Medical Products.
Our Team is a Preferred Research and Strategy Partner of Top Pharmaceutical and Device Manufacturers.
NOVEL has a Large Network of Internal and External Stakeholders, including KOLs, Payers and Patient Advocacy Groups.
NOVEL was selected for 23 peer-reviewed presentations at ISPOR Baltimore. NOVEL was also selected for PODIUM session and two award-finalists. Watch 1 minute Replay of our Podium Presentation.
NOVEL recently published an indirect treatment comparison for a breakthrough therapy for tardive dyskinesia
At the Health Technology Assessment HTAi Annual Meeting in Seoul, Korea, NOVEL's team was selected for podium and poster presentations.
NOVEL just published a comprehensive overview on all Breakthrough Therapy Designated products, covering their clinical, HEOR, and comparative effectiveness.
NOVEL's team won two Platinum and Bronze Medal Awards for Presentations at AMCP Nexus Educational Conference at Boston.
NOVEL's team presented nineteen studies on HEOR and market access trends at the 18th Annual International ISPOR meeting in New Orleans.
Our annual strategy series has been cited and quoted more than two hundred times.
NOVEL's team and leading stakeholders hosted a 1 day workshop on Market Access & Reimbursement Strategy in Copenhagen.